在皮肤T细胞淋巴瘤中IL-4和IL-13的作用
Roberto Mazzetto1, Paola Miceli1, Jacopo Tartaglia1
1Dermatology Unit, Department of Medicine (DIMED), University of Padua, 35121 Padova, Italy.
Life (Basel, Switzerland)
|February 24, 2024
概括
介质蛋白IL-4和IL-13是皮肤T细胞淋巴瘤 (CTCL) 进展和的关键. 阻断这些细胞因子对治疗CTCL症状和了解疾病机制有很大的希望.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
背景情况:
- 互白蛋白IL-4和IL-13已被认为是皮肤T细胞淋巴瘤 (CTCL) 病原体的贡献者.
- 它们在CTCL相关的中所起的作用已经确立,在晚期疾病中普遍存在Th2配置文件.
研究的目的:
- 在真菌菌病和塞萨里综合征 (常见的CTCL类型) 中审查IL-4/IL-13轴.
- 检查病原遗传影响,并专注于针对IL-4/IL-13的试验性治疗方法.
主要方法:
- 对CTCL中的IL-4/IL-13轴的当前知识的文献综述.
- 对现有关于病原体影响和治疗潜力的研究进行分析.
主要成果:
- IL-4和IL-13与CTCL病变和有关.
- 阻断2型免疫细胞因子的向药物显示了CTCL的治疗潜力.
结论:
- 了解IL-4/IL-13动态对于获得CTCL进展见解至关重要.
- IL-4/IL-13轴阻塞剂可以改善CTCL的管理,阐明病理生理机制.
相关概念视频
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
T Cell Activation and Clonal Selection
732
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
732
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524


